Expiration Date: 04/02/2025
Learner Notification

*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.

Speakers
Anthony Jaworski, PharmD, BCCCP, DABAT
Clinical Program Manager - Poison Control
Children’s Hospital of Philadelphia
Has disclosed no relevant financial relationships

Liz Laubach, PharmD, BCPS, DABAT
Assistant Professor of Toxicology
Concordia University Wisconsin School of Pharmacy
Has disclosed no relevant financial relationships

Moderator
Alexandra Funk, PharmD, DABAT
Managing Director
Florida Poison Information Center - Tampa
Has disclosed no relevant financial relationships

Organizer
David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
Has disclosed no relevant financial relationships

Description

The purpose of this educational session is to describe the radiological and chemical toxicity associated with depleted uranium, review the isotopic composition of natural versus depleted uranium, and to discuss the behavior of long-residence time metal fragments in soft tissue and implications for longitudinal surveillance.

Acknowledgement of In-Kind Commercial Support

No in-kind commercial support was received for this educational activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. You must participate in the entire webinar as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Physicians and Pharmacists

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM for physicians and 1 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.

Objectives - After attending this program you should be able to:

  1. Review existing literature exploring airway management for comatose individuals.
  2. Critically evaluate the most study investigating airway management in comatose patients with acute poisoning.
  3. Review the existing literature that addresses the use of the partition coefficient (LogP) of intoxicants to guide the use of intravenous lipid emulsion therapy in poisoned patients.

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.

 

Click here to complete the Post Webinar CE Evaluation